Welcome to our dedicated page for Perimeter Medical Imaging Ai news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on Perimeter Medical Imaging Ai stock.
Perimeter Medical Imaging AI Inc (PYNKF) delivers cutting-edge imaging solutions for cancer surgery, specializing in AI-enhanced optical coherence tomography (OCT) systems. This page provides official updates on regulatory milestones, clinical research, and technological advancements shaping surgical oncology.
Investors and medical professionals will discover timely updates about the company’s FDA-cleared S-Series OCT platform, B-Series AI integration progress, and strategic partnerships. Content includes earnings reports, trial outcomes, and educational initiatives demonstrating real-world clinical impact.
Key updates cover surgical margin visualization innovations, regulatory submissions, and peer-reviewed study results. All materials are sourced directly from company filings and verified medical publications to ensure accuracy.
Bookmark this page for consolidated access to Perimeter’s latest developments in AI-driven surgical imaging. Regularly updated to reflect new achievements in precision oncology and operational growth.
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK, OTC:PYNKF) announced the outcomes of its annual shareholder meeting held on October 27, 2021. Shareholders approved all resolutions, including the re-election of nine directors and the reappointment of KPMG LLP as auditors. Additionally, the stock option plan was amended to increase common shares reserved for issuance. The company granted 1,949,663 stock options at $2.85 each. Perimeter continues to advance its imaging technologies for cancer surgery, including the FDA-cleared S-Series OCT and the ImgAssist AI project.
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) will participate in the LD Micro Main Event Investor Conference from October 12-14, 2021, in Los Angeles, CA. CEO Jeremy Sobotta will present on October 12 at 3:30 pm PT. Perimeter's S-Series Optical Coherence Tomography (OCT) is FDA-cleared and offers real-time tissue visualization, potentially improving patient outcomes. The company is also developing the B-Series OCT with ImgAssist AI, funded by a $7.4 million grant from CPRIT, aimed at reducing re-operation rates in breast cancer surgeries.
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) will present at the Lytham Partners Fall 2021 Investor Conference on October 5, 2021, at 12:30 p.m. ET. The conference aims to showcase Perimeter's advanced imaging technologies designed to enhance cancer surgery outcomes. A webcast of the presentation will be available on their website. Management will also conduct virtual one-on-one meetings during the event, running from October 5-7. Perimeter is known for its S-Series OCT and B-Series OCT with ImgAssist AI technology.
Perimeter Medical Imaging AI, a medical technology company, announced its participation in upcoming industry events focused on cancer surgery and advanced imaging tools. Key highlights include Dr. Anthony Lucci's presentation on Optical Coherence Tomography at Mayo Clinic on September 17, 2021, and a poster presentation at the College of American Pathologists Annual Meeting from September 25-28, 2021. The CEO emphasized the importance of showcasing the Perimeter S-Series OCT system, which provides real-time visualization of excised tissue. The company is also advancing its B-Series OCT with ImgAssist AI, backed by a $7.4 million grant.
Perimeter Medical Imaging AI reported its Q2 2021 financial results, highlighting a net loss of $3.24 million, a decrease from $4.66 million in Q2 2020. Operating expenses increased to $3.06 million from $2 million in the previous year. Key developments included the U.S. FDA granting Breakthrough Device Designation for its imaging systems, the achievement of a 0.94 AUC in its ImgAssist AI algorithm, and plans for a pivotal study aimed at reducing breast cancer re-operation rates.
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) announced significant progress in expanding its commercial organization, led by Chief Commercial Officer Steve Sapot. The company has hired four experienced market development managers to promote its S-Series OCT medical imaging technology in the U.S. market. Perimeter's innovative imaging system, cleared by the U.S. FDA, aims to enhance cancer surgery outcomes and reduce healthcare costs. Additionally, the company is advancing its ImgAssist AI technology under the ATLAS AI project, supported by a US$7.4 million grant.
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) has announced that its common shares are now eligible for electronic clearing and settlement through The Depository Trust Company (DTC) in the U.S. This DTC eligibility aims to increase liquidity and enhance the company's presence in U.S. capital markets. CEO Jeremy Sobotta highlighted the benefits for existing shareholders, including faster execution speeds and greater opportunities to attract new investors. The company's imaging technology, including S-Series and B-Series OCT systems, is designed to improve cancer surgery outcomes.
Perimeter Medical Imaging AI (OTC:PYNKF), a leader in medical imaging technology, will participate in the 6th Annual Needham Virtual Med Tech & Diagnostics Conference on August 16-17, 2021. CEO Jeremy Sobotta will hold one-on-one virtual meetings during the event. Perimeter's FDA-cleared S-Series Optical Coherence Tomography (OCT) offers real-time visualization of excised tissue, potentially enhancing surgical outcomes. The company is also developing the B-Series OCT with ImgAssist AI, backed by a $7.4 million CPRIT grant, aimed at improving breast conservation surgery outcomes.
Perimeter Medical Imaging AI (TSX-V:PINK)(OTC:PYNKF) has appointed Dr. Sarah Butler as Vice President of Clinical and Medical Affairs, effective immediately. CEO Jeremy Sobotta expressed enthusiasm over Butler's expertise in medical affairs, expecting her to enhance clinical strategies as the company prepares for a pivotal study of its ImgAssist AI software. Dr. Butler brings extensive experience from previous roles, including her tenure at IBM Watson Health. The company focuses on transforming cancer surgery with advanced imaging tools, addressing unmet medical needs.
Perimeter Medical Imaging AI (TSX-V: PINK, OTC: PYNKF) announced CEO Jeremy Sobotta will participate in the virtual Lytham Partners Summer 2021 Investor Conference panel on breast cancer innovations on June 15, 2021, at 5:00 PM ET. The event runs from June 14-16, 2021, with one-on-one meetings available. Perimeter's FDA-cleared S-Series Optical Coherence Tomography (OCT) enhances real-time visualization during surgery, aiming for improved patient outcomes. The B-Series OCT, supported by a $7.4 million CPRIT grant, is set for a pivotal study to evaluate its impact on breast cancer surgery.
